Melinda Aldrich Archive — Page 1 of 1

September 18, 2026

Vanderbilt-Ingram Cancer Center convenes dual retreats to drive lung cancer care and research forward

The retreats will reflect on progress, strengthen collaborations across disciplines and identify opportunities to further improve care for patients with lung cancer.

Melinda Aldrich, PhD, MPH
September 9, 2026

Melinda Aldrich to receive 2026 Ethos Award from UC Santa Cruz

The awards celebrate individuals whose vision, leadership and dedication have made a meaningful impact in their professions, in society, within the university community, and across the globe.

(iStock)
August 28, 2025

Genetic analysis of people with African ancestry reveals lung cancer susceptibilities  

Prior research has shown that Americans of African ancestry have a higher risk of lung cancer compared to white Americans despite smoking fewer cigarettes, but the reasons for this difference are not fully understood.

October 7, 2024

VUMC hosts International Lung Cancer Consortium meeting 

The consortium is coordinated by the International Agency for Research on Cancer with the aim of sharing data from ongoing lung cancer case-control and cohort studies.

Melinda Aldrich, PhD, MPH
September 20, 2024

Melinda Aldrich elected to genetics society board of directors

Aldrich uses population-based cohorts and biobanks to investigate lung cancer; her research informed guidelines for lung cancer screening.

March 18, 2021

Vanderbilt research played key role in new lung screen guidelines

The U.S. Preventive Services Task Force (USPSTF) has formally recommended two changes that will nearly double the number of people eligible for lung cancer screening by lowering the age from 55 to 50 and reducing the number of smoking history pack years from 30 to 20.